ArticleFrontiers in cardiovascular medicine2025
Local multifrequency impedance changes after radiofrequency ablation in human atria: potential use for tissue characterization.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05159180 (Desarrollo de un Nuevo Sistema de Mapeo de Impedancia Para la ablación de Las Arritmias Auriculares en Pacientes), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Desarrollo de un Nuevo Sistema de Mapeo de Impedancia Para la ablación de Las Arritmias Auriculares en Pacientes
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Local impedance (LI) mapping provides additional tissue characterization of the atria substrate. Measuring LI at different current frequencies has the advantage of exploring intra- and extra-cellular compartments and may add useful information about tissue integrity. The objective of this study was to characterize the changes in local multifrequency impedance (LMI) after radiofrequency ablation in human atrial tissue. Methods: In fifteen patients undergoing catheter ablation of atrial arrhythmias, we constructed a baseline high-density electroanatomical map (EAM) and measured the LMI (1-1,000 kHz) at fifty sites around the cava veins using the QDOT or Smarttouch electrocatheter. Then a point-by-point pulmonary vein isolation procedure was performed using radiofrequency energy in a temperature controlled mode (90W for 4 s for QDOT/30W for 30 s for Smarttouch). After confirming the PVI fifty additional LMI recordings per patient were performed around the initial sites. We performed an offline analysis to compare the values of bipolar voltage and LMI of blood, pre- and post-ablated tissue. We also analyzed the cardiac cycle changes of LMI and the effects of catheter orientation to the LMI, contact force and bipolar voltage. Results: A total of 641 pre-ablated and 190 post-ablated sites were studied from all patients. Blood pool, healthy and post-ablated myocardium presented distinctive LMI signatures (Z Conclusions: LMI can differentiate pre- from post-ablated tissue in a cohort of patients submitted to RF ablations. This new tool could be of potential clinical applicability for the characterization of the atrial substrate and to monitor lesion quality to perform durable ablation lesions. Clinical Trial Registration: NCT05159180 (https://www.clinicaltrials.gov); Unique Protocol ID: IIBSP-IMS-2021-74.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.